NCT07282483
Traditional Chinese Medicine Oral Liquids and Mouthwashes for Radiation-induced Oral Mucositis in Head and Neck Cancer Patients
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 4 versions: 4 with changes below. See every version on ClinicalTrials.gov ↗
- Notable Eligibility criteria expanded, about 12 words
- Primary completion date changed from estimate of Aug 31, 2026 to Oct 25, 2026
- Study completion pushed from Oct 31, 2026 to Dec 25, 2026
- Minor Study completion date: Sep 30, 2026 to Oct 31, 2026
- Start date changed from estimate of Mar 20, 2026 to Mar 16, 2026
- Secondary endpoints: 8 to 5
Notable Trial status: Not Yet Recruiting to Recruitingv2 Show 4 more changesShow less
- Start date: Dec 15, 2025 to Mar 20, 2026
- Primary completion date: Mar 31, 2026 to Aug 31, 2026
- Study completion date: May 31, 2026 to Sep 30, 2026
- Site details revised
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Incidence rate of severe oral mucositis (RTOG grade ≥ 3)
Timeframe: From the start of radiotherapy to 8 weeks after the end of radiotherapy. The evaluation period is approximately 14 to 14.5 weeks
Secondary (5)
Duration of mild-to-moderate RIOM
The time to onset of any-grade oral mucositis (OM)
RIOM remission rates at 4 and 8 weeks after completion of radiotherapy
Duration of oral mucositis (OM)
Adverse events
Arms and interventions
Qingying oral liquid and modified Da Huang-Huang Lian Xiexin mouthwashActive comparator
Placebo oral solution and mouthwashPlacebo comparator
Drugs: Qingying oral liquid and modified Da Huang-Huang Lian Xiexin mouthwash, Placebo oral solution and mouthwash
Radiation: radiotherapy
Sites
1 site in 1 country
- West China HospitalChengdu, Sichuan, China